“THERE IS A NEW AIR ABOUT INDIA”

““THERE IS A NEW AIR ABOUT THERE IS A NEW AIR ABOUT INDIA”INDIA”

ISLANDS OF EXCELLENCE IN :ISLANDS OF EXCELLENCE IN :

• EDUCATIONEDUCATION AGRICULTUREAGRICULTURE• HEALTHCAREHEALTHCARE RESEARCH RESEARCH

INDUSTRYINDUSTRY

ENGLISH`S NEW SUPERPOWERENGLISH`S NEW SUPERPOWER

WITH AN ENGLISH-SPEAKING POPULATION WITH AN ENGLISH-SPEAKING POPULATION NOW LIKELY TO HAVE SURPASSED THAT OF NOW LIKELY TO HAVE SURPASSED THAT OF BRITAIN AND THE US, INDIA IS SET TO BRITAIN AND THE US, INDIA IS SET TO BECOME A LINGUISTIC SUPER POWER.BECOME A LINGUISTIC SUPER POWER.

INDIA CURRENTLY HAS A SPECIAL PLACE IN INDIA CURRENTLY HAS A SPECIAL PLACE IN THE ENGLISH LANGUAGE RECORD BOOKS – THE ENGLISH LANGUAGE RECORD BOOKS – AS THE COUNTRY WITH THE LARGEST AS THE COUNTRY WITH THE LARGEST ENGLISH SPEAKING POPULATION IN THE ENGLISH SPEAKING POPULATION IN THE WORLD. TEN YEARS AGO THAT RECORD WAS WORLD. TEN YEARS AGO THAT RECORD WAS HELD BY THE US . NOT ANY MORE !HELD BY THE US . NOT ANY MORE !

INDIA ON TOPINDIA ON TOP

AMONG THE FASTEST GROWING ECONOMIESAMONG THE FASTEST GROWING ECONOMIES

““FOURTH LARGEST ECONOMY”:FOURTH LARGEST ECONOMY”:WASHINGTON POSTWASHINGTON POST

AMONG THE TOP FOUR FDI DESTINATIONSAMONG THE TOP FOUR FDI DESTINATIONS

MORE FII INTO INDIAN EQUITIES THAN CHINA, KOREA MORE FII INTO INDIAN EQUITIES THAN CHINA, KOREA & TAIWAN COMBINED& TAIWAN COMBINED

“ “ POTENTIALLY BIGGER LONG-TERM GROWTH STORY POTENTIALLY BIGGER LONG-TERM GROWTH STORY THAN CHINA ”: GOLDMANTHAN CHINA ”: GOLDMAN SACHSSACHS


ECONOMIST INTELLIGENCE UNIT (SEPT 04)ECONOMIST INTELLIGENCE UNIT (SEPT 04)CENTERS OF OVERSEAS INVESTMENT :CENTERS OF OVERSEAS INVESTMENT :

%% COUNTRYCOUNTRY

3939 CHINACHINA

2929 USAUSA

2828 INDIAINDIA

“ INDIA AN R & D SPOT “


LARGEST MILKY WAY !LARGEST MILKY WAY !

90 MILLION TONS IN 200490 MILLION TONS IN 2004 20 MILLION TONS MORE THAN USA,20 MILLION TONS MORE THAN USA,

THE SECOND BIG PRODUCERTHE SECOND BIG PRODUCER


NO.1 IN MANY AREAS !NO.1 IN MANY AREAS !

SUGAR PRODUCTION SUGAR PRODUCTION BANANA, PAPAYA, MANGOBANANA, PAPAYA, MANGO EGG PLANT, CAULIFLOWER, PEASEGG PLANT, CAULIFLOWER, PEAS SPICES, COCONUT, ARECNUTSPICES, COCONUT, ARECNUT


INDIAN BRANDY, BUT GLOBAL KICKINDIAN BRANDY, BUT GLOBAL KICK McDowell's NO.1 WORLD`S TOP SELLING McDowell's NO.1 WORLD`S TOP SELLING

BRAND, DISPLACES E & J BRAND, DISPLACES E & J

INDIAN MULTINATIONALSINDIAN MULTINATIONALS

DESI COMPANIES GOBBLING UP FOREIGN DESI COMPANIES GOBBLING UP FOREIGN ENTITIES !ENTITIES !

IN 2003, 40 COMPANIES TAKEN OVERIN 2003, 40 COMPANIES TAKEN OVER TATA TEA : TETLEY TEATATA TEA : TETLEY TEA TATA : DAEWOOTATA : DAEWOO ESSEL PACKAGING : PROPAK (SWISS)ESSEL PACKAGING : PROPAK (SWISS) BIGGEST CARBON BLACK : BIGGEST CARBON BLACK :

KUMARAMANGALAM BIRLAKUMARAMANGALAM BIRLA

INDIA AN R & D POWERHOUSEINDIA AN R & D POWERHOUSE

ENGLISH SPEAKING KNOWLEDGE ENGLISH SPEAKING KNOWLEDGE WORKERSWORKERS

30%-50% COST SAVING : SWATI 30%-50% COST SAVING : SWATI PIRAMALPIRAMAL

1/51/5THTH -1/7 -1/7THTH COST IN EUROPE : RANBAXY COST IN EUROPE : RANBAXY BANGALORE : FASTEST GROWING BANGALORE : FASTEST GROWING

BIOCLUSTER IN ASIABIOCLUSTER IN ASIA

THE BIOTECH INDUSTRYTHE BIOTECH INDUSTRY MORE NEW DRUG APPROVALS FROM FDA BY MORE NEW DRUG APPROVALS FROM FDA BY

BT COMPANIES THAN PHARMA IN 2004BT COMPANIES THAN PHARMA IN 2004 USA:THE BIRTHPLACE OF MODERN BT USA:THE BIRTHPLACE OF MODERN BT

TOWER OVER THE FIELD !TOWER OVER THE FIELD ! 4400 BT FIRMS WORLDWIDE4400 BT FIRMS WORLDWIDE 2200 US FIRMS PUBLICLY TRADED2200 US FIRMS PUBLICLY TRADED 2004 REVENUES $43 BILLION2004 REVENUES $43 BILLION AMERICAN INDUSTRY RAISED $17 BILLION AMERICAN INDUSTRY RAISED $17 BILLION

FROM PUBLIC & PRIVATE FUNDS IN 2004 FROM PUBLIC & PRIVATE FUNDS IN 2004 (5 TIMES THAT OF EUROPE !)(5 TIMES THAT OF EUROPE !) GERMAN BT FLOUNDEREDGERMAN BT FLOUNDERED BRITISH BT BRUISED & BLOODIED BUT BRITISH BT BRUISED & BLOODIED BUT

UNBOWED (ERNST & YOUNG)UNBOWED (ERNST & YOUNG)

ASIAN BIOTECHASIAN BIOTECH

DOMINATED BY AUSTRALIA :$2 BN, i.e. 75 % DOMINATED BY AUSTRALIA :$2 BN, i.e. 75 % OF ASIAN REVENUEOF ASIAN REVENUE

INTERESTING COMPANIES SPRINGING UP IN INTERESTING COMPANIES SPRINGING UP IN INDIA, CHINA, SINGAPORE INDIA, CHINA, SINGAPORE

SINGAPORE BIOPOLISSINGAPORE BIOPOLIS

TO HOST 2000 SCIENTISTS FROM AROUND TO HOST 2000 SCIENTISTS FROM AROUND THE WORLD INCLUDING ALLEN COLEMAN THE WORLD INCLUDING ALLEN COLEMAN OF DOLLY FAMEOF DOLLY FAME

R & D BUDGET OF $ 7 BILLION OVER 5 YEARSR & D BUDGET OF $ 7 BILLION OVER 5 YEARS

500 STUDENTS SENT ABROAD FOR Ph.D500 STUDENTS SENT ABROAD FOR Ph.D

INDIAN BIOTECH SECTORINDIAN BIOTECH SECTOR

ABLE (ASSOC. BIOTECH LED ENTERPRISES)ABLE (ASSOC. BIOTECH LED ENTERPRISES) REVENUE - $ 1 BILLIONREVENUE - $ 1 BILLION FIVE FOLD INCREASE ($ 5 BILLION) BY 2010FIVE FOLD INCREASE ($ 5 BILLION) BY 2010 EMPLOYED 9000 S & T PERSONNEL IN 2004EMPLOYED 9000 S & T PERSONNEL IN 2004 40% INCREASE IN 200540% INCREASE IN 2005

PHARMA EXPORTS TO GROW PHARMA EXPORTS TO GROW TO $6 bnTO $6 bn

INDIA IS ONE OF THE TOP FIVE INDIA IS ONE OF THE TOP FIVE MANUFACTURERS OF BULK DRUGS IN THE MANUFACTURERS OF BULK DRUGS IN THE

WORLD !WORLD !

PHARMA EXPORTS $6 bn BY 2015 FROM THE CURRENT LEVEL PHARMA EXPORTS $6 bn BY 2015 FROM THE CURRENT LEVEL OF LESS THAN $2 bnOF LESS THAN $2 bn

THE R & D ACTIVITIES ARE TARGETED BOTH AT NEW DRUG THE R & D ACTIVITIES ARE TARGETED BOTH AT NEW DRUG DISCOVERY RESEARCH AND NOVEL DRUG DELIVERY DISCOVERY RESEARCH AND NOVEL DRUG DELIVERY SYSTEMS (NDDS). THE MAJOR COMPANIES INVESTED OVER SYSTEMS (NDDS). THE MAJOR COMPANIES INVESTED OVER Rs. 1000 CRORES LAST YEAR.Rs. 1000 CRORES LAST YEAR.


SERUM INSTITUTESERUM INSTITUTETHE VACCCINE GIANT !THE VACCCINE GIANT !

LARGEST INDIAN BT COMPANYLARGEST INDIAN BT COMPANY LARGEST VACCINE PRODUCER IN THE WORLDLARGEST VACCINE PRODUCER IN THE WORLD PRODUCES 675 m DOSAGES PER DAYPRODUCES 675 m DOSAGES PER DAY DISTRIBUTED AND USED IN 137 COUNTRIES OF THE DISTRIBUTED AND USED IN 137 COUNTRIES OF THE

WORLD (W.H.O)WORLD (W.H.O) 30% OF WORLD`S CHILDREN PROTECTED BY30% OF WORLD`S CHILDREN PROTECTED BY SERUM INTITUTE`S VACCINESERUM INTITUTE`S VACCINE


INDIAN VACCINE IMPACT INDIAN VACCINE IMPACT

HAFFKINE INSTITUTE , MUMBAIHAFFKINE INSTITUTE , MUMBAI PIONEER IN POLIO VACCINE PRODUCTION PIONEER IN POLIO VACCINE PRODUCTION IMMUNISED 150 m CHILDRENIMMUNISED 150 m CHILDREN ERADICATED POLIOERADICATED POLIO HEPATITIS B VACCINESHEPATITIS B VACCINES SHANTA BIOTECHSHANTA BIOTECH BHARAT BIOTECHBHARAT BIOTECH WOCKARDT, REDDY`SWOCKARDT, REDDY`S


NEUTRACEUTICALSNEUTRACEUTICALS

PARRY NEUTRACEUTICALSPARRY NEUTRACEUTICALS

SPIRULINA, DUNALIELLASPIRULINA, DUNALIELLA

-CAROTENE, ASTAXANTHIN-CAROTENE, ASTAXANTHIN THAPARTHAPAR ABL BIOTECHNOLOGIESABL BIOTECHNOLOGIES SAMY CHEMICALSSAMY CHEMICALS


EMERGING INTERNATIONAL HUB FOR EMERGING INTERNATIONAL HUB FOR CONTRACT RESEARCHCONTRACT RESEARCH

MANY START-UP COMPANIES IN THE LAST MANY START-UP COMPANIES IN THE LAST FOUR YEARSFOUR YEARS

BPO RPO BPO RPO CRAM CRAM RESEARCH & RESEARCH & MANUFACTURINGMANUFACTURING

BIOCON (BANGALORE) SERUM INSTITUTE BIOCON (BANGALORE) SERUM INSTITUTE (PUNE), PANACEA BIOTECH (DELHI), (PUNE), PANACEA BIOTECH (DELHI), NICHOLAS PIRAMAL (MUMBAI), NOVO NICHOLAS PIRAMAL (MUMBAI), NOVO NORDSIK (BANGALORE)NORDSIK (BANGALORE)

APOLLO HOSPITAL ENTERPRISESAPOLLO HOSPITAL ENTERPRISES

CHENNAI, DELHI, HYDERABADCHENNAI, DELHI, HYDERABAD Rs 150 CRORE REVENUE IN 2004-2005Rs 150 CRORE REVENUE IN 2004-2005 40% REVENUE FROM CARDIAC CARE40% REVENUE FROM CARDIAC CARE 39% REVENUE FROM PHARMA BUSINESS39% REVENUE FROM PHARMA BUSINESS TO SET UP SEVEN 120 BED HOSPITALS IN MINI-TO SET UP SEVEN 120 BED HOSPITALS IN MINI-

METROSMETROS MOU WITH JOHNS HOPKINS MEDICINE MOU WITH JOHNS HOPKINS MEDICINE

INTERNATIONALINTERNATIONAL TO SET UP CENTRAL REFERENCE LABS IN CHENNAI, TO SET UP CENTRAL REFERENCE LABS IN CHENNAI,

HYDERABAD AND DELHI - HIGH END CLINICAL HYDERABAD AND DELHI - HIGH END CLINICAL TESTINGTESTING

TO SET UP INSTITUTE OF MINIMAL INVASIVE TO SET UP INSTITUTE OF MINIMAL INVASIVE SURGERYSURGERY

COLLABORATIVE R & DCOLLABORATIVE R & D

RANBAXY : MEDICINES FOR MALARIA RANBAXY : MEDICINES FOR MALARIA VENTURE (MMV) GENEVAVENTURE (MMV) GENEVA

ANTIMALARIAL MOLECULE - Rbx 11160ANTIMALARIAL MOLECULE - Rbx 11160 RANBAXY : GLAXO SMITH KLINERANBAXY : GLAXO SMITH KLINE Dr. REDDY`S, ZYDUS CADILA,Dr. REDDY`S, ZYDUS CADILA, NICHOLAS PIRAMAL (EMERGING NICHOLAS PIRAMAL (EMERGING

ACTIVITIES)ACTIVITIES)

BIOCON TIES WITH NOBEX TO BIOCON TIES WITH NOBEX TO DEVELOP ORAL INSULINDEVELOP ORAL INSULIN

BIOCON HAS ENTERED INTO A RESEARCH COLLABORATION BIOCON HAS ENTERED INTO A RESEARCH COLLABORATION WITH NORTH CAROLINA`S NOBEX CORPORATION TO JOINTLY WITH NORTH CAROLINA`S NOBEX CORPORATION TO JOINTLY DEVELOP ORAL INSLIN FOR THE GLOBAL AND INDIAN DEVELOP ORAL INSLIN FOR THE GLOBAL AND INDIAN MARKETMARKET

ORCHID CHEM`S IPR FILE COUNT TOUCHES 200ORCHID CHEM`S IPR FILE COUNT TOUCHES 200

FILINGS FOR NEW DRUGS, DISCOVERY SYSTEMS AT FILINGS FOR NEW DRUGS, DISCOVERY SYSTEMS AT 25% OF TOTAL25% OF TOTAL

FIIS TO HIKE STAKE IN ORCHID CHEMICALSFIIS TO HIKE STAKE IN ORCHID CHEMICALS

ORCHID JOINS PAR PHARMA TO MARKET GENERICS IN ORCHID JOINS PAR PHARMA TO MARKET GENERICS IN USUS

ORCHID WANTS TO CRACK ORAL CEPHALOSPORIN ORCHID WANTS TO CRACK ORAL CEPHALOSPORIN FORMULATIONS MARKETFORMULATIONS MARKET

ORCHID FILES ANDA FOR CEFAZOLINORCHID FILES ANDA FOR CEFAZOLIN

ORCHID CHEMICALS & ORCHID CHEMICALS & PHARMACEUTICALS LTD.PHARMACEUTICALS LTD.

300 SCIENTIFIC PERSONNEL300 SCIENTIFIC PERSONNEL 400 BY 2006400 BY 2006 Rs. 150 CRORES IN R & D DURING LAST 7 Rs. 150 CRORES IN R & D DURING LAST 7

YEARSYEARS FDA/GLP ANIMAL FACILITY, LABSFDA/GLP ANIMAL FACILITY, LABS ANTI-INFLAMATORY, OBESITY, CANCER, ANTI-INFLAMATORY, OBESITY, CANCER,

HERBAL MEDICINEHERBAL MEDICINE TARGET : $1 bn BY 2010TARGET : $1 bn BY 2010 JV IN USA, ITALY , CHINAJV IN USA, ITALY , CHINA

PEP PILL: GLOBAL BIZ FORM 60% OF SALES PEP PILL: GLOBAL BIZ FORM 60% OF SALES NOWNOW

WOCKHARDT EYES ANOTHER EUROPEAN WOCKHARDT EYES ANOTHER EUROPEAN TAKEOVERTAKEOVER

AFTER ACQUIRING THREE EUROPEAN COMPANIES AFTER ACQUIRING THREE EUROPEAN COMPANIES IN THE PAST, IT IS LOOKING TO ACQUIRE ONE MORE IN THE PAST, IT IS LOOKING TO ACQUIRE ONE MORE EUROPEAN COMPANYEUROPEAN COMPANY

WOCKHARDT BUYS GERMAN FIRMWOCKHARDT BUYS GERMAN FIRM* * DRL ACQUIRES TRIGENESIS OF USDRL ACQUIRES TRIGENESIS OF US TORRENT PHARMA TO ACQUIRE GERMAN CO FOR Rs TORRENT PHARMA TO ACQUIRE GERMAN CO FOR Rs

300 CRORE300 CRORE JUBILANT ORGANOSYS ACQUIRES TWO BELGIAN JUBILANT ORGANOSYS ACQUIRES TWO BELGIAN

PHARMA FIRMSPHARMA FIRMS Rs 75 CRORE DEAL TO STRENGTHEN PRESENCE IN Rs 75 CRORE DEAL TO STRENGTHEN PRESENCE IN

EU, ITS MAIN EXPORT MARKETEU, ITS MAIN EXPORT MARKET WYETH SELLS BULK DRUGS PLANT TO RUNWAL WYETH SELLS BULK DRUGS PLANT TO RUNWAL

GROUP FOR Rs 60 CROREGROUP FOR Rs 60 CRORE

NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH

HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS

GROUP, AND CHOLESTECH, A US-BASED COMPANY.

STRAND IN DEAL WITH US CO FOR MICROARRAY PLATFORM

HAS ENTERED INTO AN AGREEMENT WITH US MAJOR AFFYMETRIX,

FOR PROVIDING MICROARRAY PLATFORM

MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF THOUSANDS OF GENES IN A SINGLE EXPERIMENT.

SHASUN HIKES CONTRACT THRUST

USFDA-COMPLIANT R&D (RESEARCH AND DEVELOPMENT) CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35 CRORE.

THE NEW FACILITY WOULD HOUSE ABOUT EIGHT LABORATORIES AND NEARLY 300 SCIENTISTS.

MALLADI DRUGS ACQUIRES U.S. FIRM

SUN PHARMA’S PLANS FOR US BUY GET A BOOST

ZYDUS CADILA UPPING PRESENCE ABROAD

CLINICAL RESEARCHCLINICAL RESEARCH

$ 1 BILLION BY 2008$ 1 BILLION BY 2008 BIOCON – CLINIGENEBIOCON – CLINIGENE RELIANCE CLINICAL RESEARCH SERVICES RELIANCE CLINICAL RESEARCH SERVICES

QUINTILES : WORLD`S QUINTILES : WORLD`S LARGEST CLINICAL RESEARCH LARGEST CLINICAL RESEARCH

OUTFITOUTFIT

IN INDIA SINCE 1997IN INDIA SINCE 1997 MUMBAI, AHMEDABAD, BANGALOREMUMBAI, AHMEDABAD, BANGALORE 900 PEOPLE 900 PEOPLE 2000 PEOPLE BY 20082000 PEOPLE BY 2008

MERCK & CO $40 bn US GIANTMERCK & CO $40 bn US GIANT

WITH APOTHECARIES LTDWITH APOTHECARIES LTD

(DELHI, CRO)(DELHI, CRO)

CLINICAL TRIALS ACROSS 20 CENTERS CLINICAL TRIALS ACROSS 20 CENTERS IN INDIA FOR ANTIBIOTIC , CANCERIN INDIA FOR ANTIBIOTIC , CANCER

SRL-RANBAXY IN TIE-UP WITH UK SRL-RANBAXY IN TIE-UP WITH UK HOSPITALS GROUPHOSPITALS GROUP

PATHOLOGY TESTING IN INDIA PATHOLOGY TESTING IN INDIA

NINE LABS IN INDIA, MAIN LAB IN NINE LABS IN INDIA, MAIN LAB IN MUMBAIMUMBAI

CCMB SPOTS GENETIC JACKPOT IN INDIA

WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED ENDOGAMOUS POPULATIONS –

OF WHICH 532 ARE TRIBES, INCLUDING 72 PRIMITIVE POPULATIONS, INDIA IS A BIGGER LABORATORY THAN ICELAND TO STUDY POPULATION/COMMUNITY-BASED GENETIC DISEASES.

BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT THE COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.

ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH GENETIC DISEASES IN INDIA.

GSK BIO TARGETS INDIA FOR R & DGSK BIO TARGETS INDIA FOR R & D

GLAXO SMITH KLINE BIOLOGICALS, THE VACCINE GLAXO SMITH KLINE BIOLOGICALS, THE VACCINE BUSINESS OF GLAXO SMITH KLINE (GSK), WILL BUSINESS OF GLAXO SMITH KLINE (GSK), WILL MAKE INDIA A GLOBAL HUB FOR CLINICAL MAKE INDIA A GLOBAL HUB FOR CLINICAL RESEARCH AND DEVELOPMENTRESEARCH AND DEVELOPMENT

HI-TECH VACCINES FOR AIDS, DENGUE, MALARIA HI-TECH VACCINES FOR AIDS, DENGUE, MALARIA AND TBAND TB

THE TB VACCINE TO START PHASE II TRIALS IN THE TB VACCINE TO START PHASE II TRIALS IN INDIAINDIA

PEP PILL:SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.

ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.

GE HEALTHCAREGE HEALTHCARE

SOME OF US GROW UP TO BE ENGINEERS OR SOME OF US GROW UP TO BE ENGINEERS OR DOCTORSDOCTORS

SOME OF US GROW UP TO BE BOTH !SOME OF US GROW UP TO BE BOTH !

MEDICAL IMAGING AND INFORMATION TECHNOLOGIESMEDICAL IMAGING AND INFORMATION TECHNOLOGIES MEDICAL DIAGNOSTICSMEDICAL DIAGNOSTICS PATIENT MONITORING SYSTEMS, DISEASE RESEARCH, PATIENT MONITORING SYSTEMS, DISEASE RESEARCH,

DRUG DISCOVERY AND BIOPHARMACEUTICALSDRUG DISCOVERY AND BIOPHARMACEUTICALS EARLY DETECTION OF DISEASE AND TREATMENT OF EARLY DETECTION OF DISEASE AND TREATMENT OF

CONDITIONS LIKE CANCER, ALZHEIMER`S AND CONDITIONS LIKE CANCER, ALZHEIMER`S AND CARDIOVASCULAR DISEASESCARDIOVASCULAR DISEASES

GTO INDIA HAS OVER 90 PATENTS TO ITS CREDIT AND OVER GTO INDIA HAS OVER 90 PATENTS TO ITS CREDIT AND OVER 100 INVENTION DISCLOSURES IN THE YEAR 2003 ALONE100 INVENTION DISCLOSURES IN THE YEAR 2003 ALONE..

GENETICS SPECIALTIES GENETICS SPECIALTIES LAUNCHEDLAUNCHED

CANCER GENETICS, A BIOTECHNOLOGY CANCER GENETICS, A BIOTECHNOLOGY COMPANY BASED IN THE US, HAS COMPANY BASED IN THE US, HAS ANNOUNCED THE LAUNCH OF GENETICS ANNOUNCED THE LAUNCH OF GENETICS SPECIALTIES IN BANGALORE.SPECIALTIES IN BANGALORE.

GENETIC DIAGNOSTIC TOOL FOR INDIAN GENETIC DIAGNOSTIC TOOL FOR INDIAN HEALTH MARKETHEALTH MARKET

GM RESEARCH THRIVING IN GM RESEARCH THRIVING IN INDIAN ACADEMIAINDIAN ACADEMIA

WHEAT, RICE, SUGARCANE, TOBACCO BANANA, WHEAT, RICE, SUGARCANE, TOBACCO BANANA, VEGIES, POTATO, OIL SEEDSVEGIES, POTATO, OIL SEEDS

$15 MILLION/YEAR GOVT. LABS$15 MILLION/YEAR GOVT. LABSVsVs

$ 10 MILLION/ YEAR BY SEED COST,$ 10 MILLION/ YEAR BY SEED COST,20 GOVT. INSTITUTES ON 16 CROPS20 GOVT. INSTITUTES ON 16 CROPS

SEVERAL PRIVATE COMPANIES ON 10 CROPSSEVERAL PRIVATE COMPANIES ON 10 CROPS IARI, JNU, NCPGR, U. DELHI, MKU, SRI (CBE), NBRI, IARI, JNU, NCPGR, U. DELHI, MKU, SRI (CBE), NBRI,

TNAU, ICRISAT.TNAU, ICRISAT.

ICRISAT, HYDERABADICRISAT, HYDERABAD

WORLD`S FIRST TRANSGENIC GROUNDNUT: WORLD`S FIRST TRANSGENIC GROUNDNUT: RESISTANCE TO INDIAN PEANUT CLAMP RESISTANCE TO INDIAN PEANUT CLAMP VIRUS ; ROSETTE DISEASE IN AFRICAVIRUS ; ROSETTE DISEASE IN AFRICA

TRANSGENIC BT PIGEONPEA, CHICKPEATRANSGENIC BT PIGEONPEA, CHICKPEA

GM CROPS RESEARCH IN INDIAGM CROPS RESEARCH IN INDIA

RALLIS INDIA (TATAS)RALLIS INDIA (TATAS) RASI, NUSIVEEDU, NAVBHARAT, ANKUR, RASI, NUSIVEEDU, NAVBHARAT, ANKUR,

METAHELIX, AVESTHAGEN METAHELIX, AVESTHAGEN INDO-AMERICAN HYBRID SEEDSINDO-AMERICAN HYBRID SEEDS MONSANTO/MAHICOMONSANTO/MAHICO SYNGENTA (SWISS)SYNGENTA (SWISS) BAYER/ PROAGRO(GERMANY)BAYER/ PROAGRO(GERMANY)

GM COTTON WILL TREBLEGM COTTON WILL TREBLE

TO 3.3 m Acres !TO 3.3 m Acres !(FROM 1.0 m Acres)(FROM 1.0 m Acres)

INDIA LARGEST COTTON ACREAGEINDIA LARGEST COTTON ACREAGE BUT VERY LOW PRODUCTION/ACREBUT VERY LOW PRODUCTION/ACRE GM SURGE MOSTLY ILLEGAL PLANTINGGM SURGE MOSTLY ILLEGAL PLANTING

THE LAS VEGAS PILLTHE LAS VEGAS PILL

PFIZER`S ANGINA DRUG TEST !PFIZER`S ANGINA DRUG TEST ! MALE VOLUNTEERS NOTED UNUSUAL MALE VOLUNTEERS NOTED UNUSUAL

CONSEQUENCECONSEQUENCE COMPOUND UK - 92480 BECAME COMPOUND UK - 92480 BECAME VIAGRAVIAGRA USE OF DOPAMINE AGONISTS : COMPULSIVE USE OF DOPAMINE AGONISTS : COMPULSIVE

GAMBLERS, ALCOHOLICS, GLUTTONS, SEX GAMBLERS, ALCOHOLICS, GLUTTONS, SEX PESTSPESTS

BORED WITH BREAD AND BUTTER BORED WITH BREAD AND BUTTER BIOTECH !BIOTECH !

GO MAKE GREAT WINES !GO MAKE GREAT WINES !

SIX BANKERS (INCLUDING TWO INDIANS) SIX BANKERS (INCLUDING TWO INDIANS) LEGENDARY MEAL AT CELEBRATED CHEF LEGENDARY MEAL AT CELEBRATED CHEF GORDON RAMSAY`S PETRUS RESTAURANT IN GORDON RAMSAY`S PETRUS RESTAURANT IN LONDON: SPLASHED £ 44000LONDON: SPLASHED £ 44000

CERTIFIED MOST EXPENSIVE MEAL BY CERTIFIED MOST EXPENSIVE MEAL BY GUINESS BOOK OF RECORDSGUINESS BOOK OF RECORDS

1947 CHATEAU PETRUS BORDEAUX : £12300 1947 CHATEAU PETRUS BORDEAUX : £12300 (Rs.10 LAKHS)(Rs.10 LAKHS)

TWO WINES : £ 11600 AND £ 9400TWO WINES : £ 11600 AND £ 9400

NICHOLAS PIRAMAL PLANS BIG DIAGNOSTICS PUSH

HAS SIGNED ALLIANCES WITH DIASYS GMBH, A GERMAN FIRM,HYPOGUARD, A UK-BASED COMPANY PART OF THE MEDISYS

GROUP, AND CHOLESTECH, A US-BASED COMPANY.

INDIA ON TOPINDIA ON TOPRELIANCE INDUSTRIES IS THE WORLD`S :RELIANCE INDUSTRIES IS THE WORLD`S :

22NDND LARGEST PRODUCER OF POLYFIBER AND YARN LARGEST PRODUCER OF POLYFIBER AND YARN 33RDRD LARGEST PRODUCER OF PARAXYLENE LARGEST PRODUCER OF PARAXYLENE 55THTH LARGEST PRODUCER OF PURIFIED TEREPTHALIC ACID (PTA) LARGEST PRODUCER OF PURIFIED TEREPTHALIC ACID (PTA) IT COMBINES THE PEPTIDE PRODUCTION CAPABILITIES OF BIOCON WITH IT COMBINES THE PEPTIDE PRODUCTION CAPABILITIES OF BIOCON WITH

THE PEPTIDE BASED ORAL-DELIVERY TECHNOLOGY OF NOBEX.THE PEPTIDE BASED ORAL-DELIVERY TECHNOLOGY OF NOBEX.

BIOCON TIES UP WITH VACCINEX FOR ANTIBODIESBIOCON TIES UP WITH VACCINEX FOR ANTIBODIES

BIOCON WITH ROCHESTER (NEW YORK) - BASED VACCINEX TO PURSUE BIOCON WITH ROCHESTER (NEW YORK) - BASED VACCINEX TO PURSUE DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES (MAbs) TO DEVELOPMENT OF THERAPEUTIC MONOCLONAL ANTIBODIES (MAbs) TO ADD TO THEIR DISCOVERY PIPELINE.ADD TO THEIR DISCOVERY PIPELINE.

GLOBAL PROJECTED SALES OF MAbs IS EXPECTED TO TOUCH $13 bn BY GLOBAL PROJECTED SALES OF MAbs IS EXPECTED TO TOUCH $13 bn BY 20102010

THE SCRIPTING OF INDIA NO.1THE SCRIPTING OF INDIA NO.1

THE LIST OF DESI COS POSSESSING WORLD CLASS SIZE AND SCALES GROWINGTHE LIST OF DESI COS POSSESSING WORLD CLASS SIZE AND SCALES GROWING

UB GROUP, WHICH WITH THE ACQUITION OF SHAW WALLACE HAS BECOME THE UB GROUP, WHICH WITH THE ACQUITION OF SHAW WALLACE HAS BECOME THE SECOND LARGEST LIQUOR COMPANY IN THE WORLD AFTER DIAGEOSECOND LARGEST LIQUOR COMPANY IN THE WORLD AFTER DIAGEO

HERO HONDA IS SET TO END THE CURRENT FISCAL AS THE LARGEST TWO WHEELER HERO HONDA IS SET TO END THE CURRENT FISCAL AS THE LARGEST TWO WHEELER COMPANY IN THE WORLD FOR THE FOURTH YEAR IN SUCCESSION.COMPANY IN THE WORLD FOR THE FOURTH YEAR IN SUCCESSION.

HERO GROUP COMPANY, HERO CYCLES, IS THE LARGEST COMPANY WITH ANNUAL HERO GROUP COMPANY, HERO CYCLES, IS THE LARGEST COMPANY WITH ANNUAL PRODUCTION OF 5.4 mn BICYCLESPRODUCTION OF 5.4 mn BICYCLES

ESSEL PROPACK IS THE WORLD`S LARGEST MANUFACTURER OF LAMINATED TUBES.ESSEL PROPACK IS THE WORLD`S LARGEST MANUFACTURER OF LAMINATED TUBES.

GLOBAL MARKETSHARE OF MORE THAN 30%, HAS MANUFACTURING FACILITIES IN GLOBAL MARKETSHARE OF MORE THAN 30%, HAS MANUFACTURING FACILITIES IN CHINA,USA,GERMANY,MEXICO,COLUMBIA, VENEZUELA, PHILIPPINES, INDONESIA, CHINA,USA,GERMANY,MEXICO,COLUMBIA, VENEZUELA, PHILIPPINES, INDONESIA, EGYPT AND NEPAL.EGYPT AND NEPAL.

BHARAT FORGE IS THE WORLD`S SECOND LARGEST COMPANYBHARAT FORGE IS THE WORLD`S SECOND LARGEST COMPANY

SUNDARAM FASTENERS IS THE WORLD`S THIRD LARGEST BRAKE LINING, FASTENER SUNDARAM FASTENERS IS THE WORLD`S THIRD LARGEST BRAKE LINING, FASTENER AND RADIATOR CAPS MANUFACTURERSAND RADIATOR CAPS MANUFACTURERS

TATA TEA AND ITS SUBSIDIARY TATA TETLEY TOGETHER CONSTITUTE THE SECOND TATA TEA AND ITS SUBSIDIARY TATA TETLEY TOGETHER CONSTITUTE THE SECOND LARGEST BRANDED PORTFOLIO IN THE WORLD.LARGEST BRANDED PORTFOLIO IN THE WORLD.

STRAND IN DEAL WITH US CO FOR MICROARRAY PLATFORM

HAS ENTERED INTO AN AGREEMENT WITH US MAJOR AFFYMETRIX, FOR PROVIDING MICROARRAY PLATFORM

MICROARRAYS ARE POWERFUL TOOLS THAT ALLOW SCIENTISTS TO MEASURE AND COMPARE THE EXPRESSION LEVELS OF THOUSANDS OF GENES IN A SINGLE EXPERIMENT.

CONTRACT RESEARCH AND CONTRACT RESEARCH AND AMNUFACTURING(CRAM)AMNUFACTURING(CRAM)

TCSTCS INFOSYSINFOSYS WIPROWIPRO HCL TECHNOLOGIESHCL TECHNOLOGIES ITTIAMITTIAM SASKENSASKEN BIOCONBIOCON SHASUNSHASUN DIVI`SDIVI`S

INDIAN MULTINATIONALSINDIAN MULTINATIONALS

MANY INDIAN COMPANIES IN DRAGON MANY INDIAN COMPANIES IN DRAGON COUNTRY !COUNTRY !

INFOSYS, TCS, SUNDARAM FASTENERS, INFOSYS, TCS, SUNDARAM FASTENERS, BHARAT FORGEBHARAT FORGE

RANBAXY NOW SELLS MORE ABROAD THAN RANBAXY NOW SELLS MORE ABROAD THAN IN INDIA IN INDIA

HAS SUBSIDIES IN MORE THAN 12 HAS SUBSIDIES IN MORE THAN 12 COUNTRIESCOUNTRIES

SHASUN HIKES CONTRACT THRUST

USFDA-COMPLAINT R&D (RESEARCH AND DEVELOPMENT) CENTRE NEAR CHENNAI AT AN INVESTMENT OF ABOUT RS.35 CRORE.

THE NEW FACILITY WOULD HOUSE ABOUT EIGHT LABORATORIES AND NEARLY 300 SCIENTISTS.

CCMB SPOTS GENETIC JACKPOT IN INDIA

WITH ITS 4,635 ANTHROPOLOGICALLY WELL-DEFINED ENDOGAMOUS POPULATIONS-OF WHICH 532 ARE TRIBES, INCLUDING 72 PRIMITIVE POPULATIONS, INDIA IS A BIGGER LABORATORY THAN ICELAND TO STUDY POPULATION/COMMUNITY-BASED GENETIC DISEASES.

BIOCON CHAIRMAN KIRAN MAZUMDAR-SHAW ARGUES THAT THE COUNTRY’S UNIQUE GENE POOLS ARE “GOLD MINES”.

ABOUT 50 MILLION INDIVIDUALS ARE AFFECTED WITH GENETIC DISEASES IN INDIA.

PEP PILL : SANDOZ INVESTS $13M IN THIRD FACILITY IN INDIA.

ROCHE DIAGNOSTICS EYES INDIA FOR PRODUCTION, R&D.

“THERE IS A NEW AIR ABOUT INDIA”

Documents

Transcript of “THERE IS A NEW AIR ABOUT INDIA”